VIDEO: What’s known so far about plasma exchange in MS, neuromyelitis optica

DALLAS – Plasma exchange, or PLEX, is a type of therapeutic apheresis that has been shown to be effective for acute attacks of demyelinating disease, but it’s not to be used for treatment of chronic or progressive multiple sclerosis.

Dr. Brian G. Weinshenker, professor of neurology at the Mayo Clinic College of Medicine in Rochester, Minn., summarized the current evidence and indications for plasma exchange in individuals with multiple sclerosis or neuromyelitis optica and shared a few practice tips at a meeting of the Consortium of Multiple Sclerosis Centers and the Americas Committee for Treatment and Research in Multiple Sclerosis. 

For the latest guidelines, visit the American Academy of Neurology and the American Society for Apheresis.

nmiller@frontlinemedcom.com On Twitter @naseemsmiller

DALLAS – Plasma exchange, or PLEX, is a type of therapeutic apheresis that has been shown to be effective for acute attacks of demyelinating disease, but it’s not to be used for treatment of chronic or progressive multiple sclerosis.

Dr. Brian G. Weinshenker, professor of neurology at the Mayo Clinic College of Medicine in Rochester, Minn., summarized the current evidence and indications for plasma exchange in individuals with multiple sclerosis or neuromyelitis optica and shared a few practice tips at a meeting of the Consortium of Multiple Sclerosis Centers and the Americas Committee for Treatment and Research in Multiple Sclerosis. 

For the latest guidelines, visit the American Academy of Neurology and the American Society for Apheresis.

nmiller@frontlinemedcom.com On Twitter @naseemsmiller

DALLAS – Plasma exchange, or PLEX, is a type of therapeutic apheresis that has been shown to be effective for acute attacks of demyelinating disease, but it’s not to be used for treatment of chronic or progressive multiple sclerosis.

Dr. Brian G. Weinshenker, professor of neurology at the Mayo Clinic College of Medicine in Rochester, Minn., summarized the current evidence and indications for plasma exchange in individuals with multiple sclerosis or neuromyelitis optica and shared a few practice tips at a meeting of the Consortium of Multiple Sclerosis Centers and the Americas Committee for Treatment and Research in Multiple Sclerosis. 

For the latest guidelines, visit the American Academy of Neurology and the American Society for Apheresis.

nmiller@frontlinemedcom.com On Twitter @naseemsmiller